A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects

This study is testing the safety and how the body processes a new experimental drug called GEn-1124 after a single oral dose, in healthy adult men. This is an early-phase trial to understand how the drug is absorbed and eliminated from the body. **You may be eligible if...** - You are a healthy man aged 18–55 - Your BMI is between 18 and 32 - You are willing to follow all study rules, including dietary restrictions and exercise limitations **You may NOT be eligible if...** - You are taking prohibited medications or have significant health conditions - You use tobacco or nicotine products regularly - You have consumed caffeine or alcohol recently - You have had a major surgery or hospital stay in the past 30 days - You have participated in another drug trial in the past 90 days - You are an employee or family member of the study site Talk to your doctor to see if this trial is right for you.